These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38604209)

  • 21. Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial.
    Hausenloy DJ; Kharbanda RK; Møller UK; Ramlall M; Aarøe J; Butler R; Bulluck H; Clayton T; Dana A; Dodd M; Engstrom T; Evans R; Lassen JF; Christensen EF; Garcia-Ruiz JM; Gorog DA; Hjort J; Houghton RF; Ibanez B; Knight R; Lippert FK; Lønborg JT; Maeng M; Milasinovic D; More R; Nicholas JM; Jensen LO; Perkins A; Radovanovic N; Rakhit RD; Ravkilde J; Ryding AD; Schmidt MR; Riddervold IS; Sørensen HT; Stankovic G; Varma M; Webb I; Terkelsen CJ; Greenwood JP; Yellon DM; Bøtker HE;
    Lancet; 2019 Oct; 394(10207):1415-1424. PubMed ID: 31500849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.
    Holman RR; Coleman RL; Chan JCN; Chiasson JL; Feng H; Ge J; Gerstein HC; Gray R; Huo Y; Lang Z; McMurray JJ; Rydén L; Schröder S; Sun Y; Theodorakis MJ; Tendera M; Tucker L; Tuomilehto J; Wei Y; Yang W; Wang D; Hu D; Pan C;
    Lancet Diabetes Endocrinol; 2017 Nov; 5(11):877-886. PubMed ID: 28917545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial.
    Park SJ; Ahn JM; Kang DY; Yun SC; Ahn YK; Kim WJ; Nam CW; Jeong JO; Chae IH; Shiomi H; Kao HL; Hahn JY; Her SH; Lee BK; Ahn TH; Chang KY; Chae JK; Smyth D; Mintz GS; Stone GW; Park DW;
    Lancet; 2024 May; 403(10438):1753-1765. PubMed ID: 38604213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease: the ALL-HEART RCT and economic evaluation.
    Mackenzie IS; Hawkey CJ; Ford I; Greenlaw N; Pigazzani F; Rogers A; Struthers AD; Begg AG; Wei L; Avery AJ; Taggar JS; Walker A; Duce SL; Barr RJ; Dumbleton JS; Rooke ED; Townend JN; Ritchie LD; MacDonald TM;
    Health Technol Assess; 2024 Mar; 28(18):1-55. PubMed ID: 38551218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implantation of the coronary sinus reducer for refractory angina due to coronary microvascular dysfunction in the context of apical hypertrophic cardiomyopathy-a case report.
    Cheng K; Keramida G; Baksi AJ; de Silva R
    Eur Heart J Case Rep; 2022 Nov; 6(11):ytac440. PubMed ID: 36415685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Coronary Sinus Reducer implantation: a new treatment for chronic refractory angina].
    Giannini F; Aurelio A; Chieffo A
    G Ital Cardiol (Rome); 2016 Oct; 17(10 Suppl 1):3S-9. PubMed ID: 27729662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.
    Bhatt DL; Steg PG; Mehta SR; Leiter LA; Simon T; Fox K; Held C; Andersson M; Himmelmann A; Ridderstråle W; Chen J; Song Y; Diaz R; Goto S; James SK; Ray KK; Parkhomenko AN; Kosiborod MN; McGuire DK; Harrington RA;
    Lancet; 2019 Sep; 394(10204):1169-1180. PubMed ID: 31484629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.
    Connolly SJ; Eikelboom JW; Bosch J; Dagenais G; Dyal L; Lanas F; Metsarinne K; O'Donnell M; Dans AL; Ha JW; Parkhomenko AN; Avezum AA; Lonn E; Lisheng L; Torp-Pedersen C; Widimsky P; Maggioni AP; Felix C; Keltai K; Hori M; Yusoff K; Guzik TJ; Bhatt DL; Branch KRH; Cook Bruns N; Berkowitz SD; Anand SS; Varigos JD; Fox KAA; Yusuf S;
    Lancet; 2018 Jan; 391(10117):205-218. PubMed ID: 29132879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.
    Ohman EM; Roe MT; Steg PG; James SK; Povsic TJ; White J; Rockhold F; Plotnikov A; Mundl H; Strony J; Sun X; Husted S; Tendera M; Montalescot G; Bahit MC; Ardissino D; Bueno H; Claeys MJ; Nicolau JC; Cornel JH; Goto S; Kiss RG; Güray Ü; Park DW; Bode C; Welsh RC; Gibson CM
    Lancet; 2017 May; 389(10081):1799-1808. PubMed ID: 28325638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of cardiac shock wave therapy in patients with stable angina: The design of randomized, triple blind, sham-procedure controlled study.
    Shkolnik E; Burneikaite G; Celutkiene J; Scherbak M; Zuoziene G; Petrauskiene B; Trush E; Laucevicius A; Vasyuk Y
    Anatol J Cardiol; 2018 Feb; 19(2):100-109. PubMed ID: 29424731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial.
    Varenne O; Cook S; Sideris G; Kedev S; Cuisset T; Carrié D; Hovasse T; Garot P; El Mahmoud R; Spaulding C; Helft G; Diaz Fernandez JF; Brugaletta S; Pinar-Bermudez E; Mauri Ferre J; Commeau P; Teiger E; Bogaerts K; Sabate M; Morice MC; Sinnaeve PR;
    Lancet; 2018 Jan; 391(10115):41-50. PubMed ID: 29102362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of coronary sinus Reducer in patients with refractory angina and diabetes mellitus.
    Vescovo GM; Zivelonghi C; Agostoni P; Dekker M; Silvis M; Leenders G; van Kuijk JP; Timmers L; Stella P; Banai S; Verheye S
    Heart Vessels; 2022 Feb; 37(2):194-199. PubMed ID: 34374824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronary sinus Reducer device for the treatment of refractory angina: A multicenter initial experience.
    Ferreira Reis J; Brízido C; Madeira S; Ramos R; Almeida M; Cacela D
    Rev Port Cardiol; 2023 May; 42(5):413-420. PubMed ID: 36828185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Achieving Optimal Medical Therapy: Insights From the ORBITA Trial.
    Foley M; Rajkumar CA; Shun-Shin M; Ganesananthan S; Seligman H; Howard J; Nowbar AN; Keeble TR; Davies JR; Tang KH; Gerber R; O'Kane P; Sharp ASP; Petraco R; Malik IS; Nijjer S; Sen S; Francis DP; Al-Lamee R
    J Am Heart Assoc; 2021 Feb; 10(3):e017381. PubMed ID: 33496201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of the coronary sinus reducer upon left ventricular function in patients with refractory angina pectoris.
    Tzanis G; Palmisano A; Gallone G; Ponticelli F; Baldetti L; Esposito A; Colombo A; Giannini F
    Catheter Cardiovasc Interv; 2020 May; 95(6):1104-1108. PubMed ID: 31373415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The challenges of a randomised placebo-controlled trial of CTO PCI vs. placebo with optimal medical therapy: The ORBITA-CTO pilot study design and protocol.
    Khan S; Fawaz S; Simpson R; Robertson C; Kelly P; Mohdnazri S; Tang K; Cook CM; Gallagher S; O'Kane P; Spratt J; Brilakis ES; Karamasis GV; Al-Lamee R; Keeble TR; Davies JR
    Front Cardiovasc Med; 2023; 10():1172763. PubMed ID: 37206100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-of-1 Trial of Angina Verification Before Percutaneous Coronary Intervention.
    Rajkumar CA; Foley MJ; Ahmed-Jushuf F; Simader FA; Mohsin M; Ganesananthan S; Nowbar AN; Chotai S; Sen S; Petraco R; Nijjer SS; Sehmi J; Ruparelia N; Dungu JN; Kabir A; Tang K; Gamma R; Davies JR; Kotecha T; Cole GD; Howard JP; Keeble TR; Clesham G; O'Kane PD; Harrell FE; Francis DP; Shun-Shin MJ; Al-Lamee RK
    J Am Coll Cardiol; 2024 Jul; 84(1):1-12. PubMed ID: 38752902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous coronary intervention versus medical therapy in patients with angina and grey-zone fractional flow reserve values: a randomised clinical trial.
    Hennigan B; Berry C; Collison D; Corcoran D; Eteiba H; Good R; McEntegart M; Watkins S; McClure JD; Mangion K; Ford TJ; Petrie MC; Hood S; Rocchiccioli P; Shaukat A; Lindsay M; Oldroyd KG
    Heart; 2020 May; 106(10):758-764. PubMed ID: 32114516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, triple-blind trial of cardiac shock-wave therapy on exercise tolerance and symptoms in patients with stable angina pectoris.
    Shkolnik E; Burneikaite G; Jakutis G; Scherbak M; Zuoziene G; Petrauskiene B; Trush E; Vasyuk Y; Laucevicius A; Celutkiene J
    Coron Artery Dis; 2018 Nov; 29(7):579-586. PubMed ID: 29912782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.